WARNING: WORLD CLASS ANALYSIS POST I’m only half a

New Post Public Reply Private Reply Replies (4) Message Board
Respert24
1,034
WARNING: WORLD CLASS ANALYSIS POST

I’m only half a bottle of St. Francis Cabernet into the evening so I’ll apologize in advance if this makes more sense than normal.

I got the latest SEC filing straight to my inbox earlier. Felt good. Hit it right in the sweet spot.

Then, like I do every time I get an email about a new filing I rush to open it up on my phone (which is what I’m usually on when these hit) and immediately start pretending like I know what the hell I’m looking at.

“Hmmm, yeah, yeah, definitely good stuff here”, I say to myself as I have to constantly zoom in and out on the 2pt font to see what the hell it says. “Must be related to the uplisting.”

Then I rush over here to see what people who aren’t me say. If it’s close to what I was guessing I get very impressed with myself.

Anyways, let’s talk about tomorrow!

Many of you haven’t been made aware (wine-induced sarcasm*) but there are a couple upcoming events related to our investments in CYDY. Tomorrow there will be a conference call to discuss updates related to ongoing efforts toward approval. Also, by the end of the month we’ll all need to vote on whether or not to sprinkle more gold on the already Scrooge McDuck-sized pool of coins at the executive gym down the street from the home office. They spray hospital grade sanitizer on the coins in between each board of director’s swim, so it’s safe. Not that they couldn’t just pull out the leronlimab vial they each carry in their suit pockets and self-inject themselves back to 100%, but you can never be too safe.

*Medical Term

(2/3rds of a bottle)

It’s probably a good idea to assume nothing good is going to come of the call so that you’re impressed when it’s over rather than disappointed.

Oh me?

I think we’re going to get something substantial.

I ran a binomial reduction of possibilities, cross referenced those against a standard Kruskal Wallis test (Thanks Google!), and then input those values into my premier league simulation software to check the results. My striker, Respert (Number 24, obviously) led the league in goals and had just nutmegged a defender when my computer screen went blue and asked if I wanted to restart in safe mode. So I think it’s “safe” to say that we’re totally going to get a major announcement tomorrow.

But what will it be?

Well, you heard it here first that…

I honestly don’t know.

But...BUT...I think we actually do get an announcement of the UK advancing Leronlimab toward approval. Something that becomes trackable and imminent. Maybe NASDAQ happens on the call, too. But regardless of the exact announcement I believe we will get something substantial toward approval and revenue. And if we don’t get anything negative (like the US or the UK declining to give us EUA, or NASDAQ telling us to shove it) we should be happy that after 30-ish days waiting on approval we haven’t been told no. That in and of itself should be a glaring positive that it’s going to get done. 30 days seems to be the reasonable timeframe for a decision. Why wait that long just to say no?

At any rate, I’m sick and tired of waiting like the rest of you. Beach houses don’t buy themselves and until I give the wife a beach house to decorate I’m stuck getting the investing equivalent of blue balls every time I wake up at 5:15 and stare at my phone until 6:00 for no PR. But as long as there isn't a roadblock thrown our way tomorrow I'll be happy. Progress is important.

(Full bottle complete)

In conclusion, now that I’m out of wine, I wish I had more facts, advice, and actionable information for you but I don’t. Just a little guess and a whole lot of fluff. Though I will predict that once we get approval we will see both an immediate jump in share price AND a steady move higher as more and more people learn about CYDY from the resulting news and jump onboard. So if you see it jump to, say, $19 with the news on the first day, I would predict that over the next 3-5 days there’s another significant increase as awareness spreads. This is why it will be difficult for me to know for sure when I pull out a small percentage of my shares to cover my initial investment or fund a pool. Not to mention that any approval brings the increased chances that all the other possibilities are more realistic than where they stand today, and that’s worth something too.

I’ll probably drink another bottle of wine tomorrow night after the call. Maybe I’ll post. I guess the question is, will it be a $15-$20 bottle of wine or a much more expensive one?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioArctic's Moves: Lecanemab Data and Leadership Insights

Updated Category News Views 46

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

Continue Reading
The Sift: Slickdeals’ Game-Changing Black Friday Tool

Updated Category News Views 221

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 98

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
SMTC: Thriving with Innovation in EMS Landscape

Updated Category News Views 0

Trailblazing in the Evolving EMS Arena SMTC's latest accolade from Frost & Sullivan isn't just another feather in their cap. It's a testament to how this mid-tier electronics manufacturing services (EMS) player stands head and shoulders above the rest. While other companies are fumbling with supply chain headaches and shifting market demands, these folks are buckling down...

Continue Reading
STARMUS VIII Merges Science and Art for Change

Updated Category News Views 78

STARMUS VIII: Where Science and Art Collide Think about this: you're basking in the Canary Islands' sun, surrounded by Nobel laureates and astronauts while the riffs of Queen's Sir Brian May soar in the air. That's exactly what went down at STARMUS VIII, a week-long celebration of science and art held in Tenerife and La Palma from October 17 to 22, 2026. A jamboree of...

Continue Reading
Deciding Between Root Canal or Tooth Extraction

Updated Category News Views 76

The Battle Between Saving and Extracting Teeth No one really talks about teeth as if they hold the keys to happiness, but let’s face it, the difference between chewing a juicy steak and wincing with every bite can be the fate of a single tooth. Dr. Carey Norton from Dacula Family Dentistry breaks down when a root canal can be an oasis of hope and when extraction is the...

Continue Reading
Modular Building Boom Shakes Up Asian Construction

Updated Category News Views 132

Building the Future, One Module at a Time What's ticking in the world of construction? Modular buildings, my friends. They're generating buzz at the Fourth Linyi Mall International Buyers Conference held last week, and for good reasons. If you're not following, China is rolling out prefabricated houses like they're the next big thing since sliced bread, leaving buyers in...

Continue Reading
ServiceNow Faces Legal Probe Amid Stock Slide

Updated Category News Views 121

Stock Turbulence Hits ServiceNow Investors Wake up and smell the market correction! ServiceNow's done slapped its shareholders with a situation no one saw coming—or maybe not. When the market opened on October 29, NYSE:NOW shares weren't just dipping; they were diving off a $29 cliff, all thanks to some sour guidance for fourth-quarter growth. Talk about financial...

Continue Reading
Are Shareholder Interests at Risk in These Deals?

Updated Category News Views 84

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Continue Reading
Benewake Unveils SR Series LiDAR for Mobile Robots

Updated Category News Views 40

Wave Goodbye to Bulky Sensors Hot off the Beijing press, Benewake's got something new—the SR Series 360° 3D LiDARs, set to stir up the robotics world. They're compact, power-efficient, and packed with smarts. It seems Benewake is tapping into a juicy market with these little sensors. Sleek Design and Big Promises The SR18 and SR96 models have a lot going for them. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Greystone Housing Impact Investors LP Restructures Financial Strategy

Updated Category News Views 68

Greystone Housing Impact Investors LP Restructures Financial Strategy Greystone Housing Impact Investors LP (NYSE:GHI) has recently taken a substantial step in its financial management by concluding a major agreement with the Federal Home Loan Mortgage Corporation. This involved redeeming its M31 Tax-Exempt Bond Securitization (TEBS) facility, which has been a component...

Continue Reading
SNC and Red 6 Forge Partnership to Innovate Military Training

Updated Category News Views 132

SNC and Red 6 Collaborate for Revolutionary Flight Training SNC, recognized globally for its leadership in aerospace and national security, has announced a strategic collaboration with Red 6. This partnership aims to transform military flight training and operations by introducing advanced training capabilities tailored for U.S. military aviation. An Innovative Beginning...

Continue Reading
Pye-Barker Fire & Safety Expands Nationwide with Strategic Growth

Updated Category News Views 221

Pye-Barker Fire & Safety Achieves Remarkable Growth Pye-Barker Fire & Safety—an industry leader known for its comprehensive fire protection, life safety, and security services—experienced significant growth in a recent year. The company successfully integrated a total of 57 acquisitions, extending its influence and services across 46 states. Such growth not only...

Continue Reading
Vera Bradley's Fiscal Q2 Results Highlight Future Growth Plans

Updated Category News Views 191

Overview of Vera Bradley's Recent Financial Performance Vera Bradley, Inc. (Nasdaq: VRA) has shared its financial results for the second quarter of the fiscal year 2025, showing a consolidated net revenue of $110.8 million. While this marks a drop from $128.2 million from the same time last year, the company remains hopeful about its future direction. Key Financial...

Continue Reading
Understanding the Trends: Columbia Banking System's Market Dynamics

Updated Category News Views 204

Columbia Banking System Inc's Short Interest Insights Columbia Banking System Inc (NYSE: COLB) has experienced a noticeable increase in its short interest, climbing 13.92% since the last assessment. Presently, there are approximately 9.71 million shares sold short, which accounts for 3.52% of the total available shares for trading. Given its current trading activity, it...

Continue Reading